{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:18:54Z","timestamp":1775110734573,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune nodopathy (AN) associated with anti-neurofascin-155 (NF155) antibodies is a distinct disorder characterized by treatment-resistant peripheral neuropathy. Although central nervous system (CNS) involvement is theorized due to the presence of NF155 in oligodendrocytes, definitive clinical reports remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 31-year-old male presented with a seven-year history of relapsing-remitting progressive sensorimotor neuropathy, tremor, and sensory ataxia. He was initially diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) and demonstrated a partial response to intravenous immunoglobulin (IVIG) and steroids. Three years after being diagnosed, he developed unilateral visual loss that progressed to no light perception accompanied by an episode of acutely elevated intraocular pressure without typical symptoms of acute glaucoma. Neurological examination revealed anisocoria, left optic atrophy, pseudoathetosis, and distal sensory deficits. Investigations confirmed markedly elevated cerebrospinal fluid (CSF) protein levels (&amp;gt;3 g\/L) and opening pressure (335 mmH\n                      <jats:sub>2<\/jats:sub>\n                      O). Both serum and CSF tested positive for anti-NF155 antibodies (titers 1:1000 and 1:32, respectively), which led to a revised diagnosis of AN. MRI of the plexus exhibited hypertrophic radiculopathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management and outcomes<\/jats:title>\n                    <jats:p>Efgartigimod, an FcRn antagonist, was initiated as an induction therapy. After receiving four weekly doses, there was noticeable improvement in his neurological function with his inflammatory neuropathy cause and treatment (INCAT) score decreasing from 4 to 3. Maintenance therapy was changed to rituximab. His INCAT score further improved to 1 at the one-year follow-up, indicating significant neurological recovery; however, the vision in his left eye did not improve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case underscores that anti-NF155 nodopathy may be associated with severe CNS complications, such as optic atrophy and intracranial hypertension, possibly because of a combination of direct antibody-mediated damage and CSF dynamic dysfunction. Additionally, in this patient, an episode of acute intraocular hypertension may have served as a further independent insult, contributing to irreversible visual loss. These findings highlight the importance of specific antibody testing in atypical CIDP cases. Moreover, the potential of a sequential treatment strategy is demonstrated, using efgartigimod for rapid induction and rituximab for maintenance as a viable and effective therapeutic approach for this complex condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1770128","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:24:50Z","timestamp":1775107490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: Unilateral optic atrophy and intracranial hypertension in anti-NF155 nodopathy: a case managed with sequential efgartigimod and rituximab"],"prefix":"10.3389","volume":"17","author":[{"given":"Lixia","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]},{"name":"Academician Workstation of The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]},{"name":"Academician Workstation of The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]},{"name":"Academician Workstation of The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-310097","article-title":"Nodopathies of the peripheral nerve: an emerging concept","volume":"86","author":"Uncini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/acn3.51550","article-title":"Clinical and diagnostic features of anti-neurofascin-155 antibody-positive neuropathy in Han Chinese","volume":"9","author":"Wang","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209725","article-title":"Antibodies in autoimmune neuropathies: What to test, how to test, why to test","volume":"103","author":"Pascual-Go\u00f1i","year":"2024","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001129","article-title":"Clinical and laboratory features in anti-NF155 autoimmune nodopathy","volume":"9","author":"Mart\u00edn-Aguilar","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2010.00245.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 first revision","volume":"15","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195406032502202","article-title":"Increased intracranial pressure caused by increased protein content in the cerebrospinal fluid","volume":"250","author":"Gardner","year":"1954","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70267","article-title":"Signs of intracranial hypertension in chronic inflammatory polyradiculoneuropathies\u2014a cross sectional cohort study","volume":"32","author":"Macher","year":"2025","journal-title":"Eur J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1503\/cmaj.110953","article-title":"Idiopathic intracranial hypertension","volume":"183","author":"Belliveau","year":"2011","journal-title":"CMAJ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-019-0129-6","article-title":"Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases","volume":"16","author":"Bothwell","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2007.00136.x","article-title":"Optic nerve imaging in multiple sclerosis","volume":"17","author":"Hickman","year":"2007","journal-title":"J Neuroimaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.260","article-title":"Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders","volume":"11","author":"Stathopoulos","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51220","article-title":"Optic, trigeminal, and facial neuropathy related to anti\u2010neurofascin 155 antibody","volume":"7","author":"Ogata","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.10.001","article-title":"Pathogenesis of optic disc edema in raised intracranial pressure","volume":"50","author":"Hayreh","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000205","article-title":"Asymmetric papilledema in idiopathic intracranial hypertension","volume":"35","author":"Bidot","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1177\/11206721211005709","article-title":"Etiology, pathogenesis and management of idiopathic intracranial hypertension, and role of optic canal size in asymmetric papilledema: A review","volume":"31","author":"Mitchell","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3171\/2014.4.JNS13932","article-title":"Diagnostic accuracy of intraocular pressure measurement for the detection of raised intracranial pressure: meta-analysis: a systematic review","volume":"121","author":"Yavin","year":"2014","journal-title":"J Neurosurg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200504","article-title":"Clinical spectrum, pathology, and mechanisms of anti-LGI4 antibody\u2013positive autoimmune nodopathy","volume":"12","author":"Zhang","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01214-x","article-title":"Therapeutic monoclonal antibody therapies in chronic autoimmune demyelinating neuropathies","volume":"19","author":"Briani","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70269","article-title":"Preliminary observations on the efficacy of efgartigimod therapy in autoimmune nodopathy","volume":"32","author":"Tai","year":"2025","journal-title":"Eur J Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00309-0","article-title":"Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial","volume":"23","author":"Allen","year":"2024","journal-title":"Lancet Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1770128\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:24:54Z","timestamp":1775107494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1770128\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2026.1770128"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1770128","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1770128"}}